Born 1960. Assoc. Prof. Rickard Brånemark, MD (1987), PhD (1996), Gothenburg University (Gothenburg, Sweden), and MSc Engineering Physics (1987), Chalmers University of Technology
Rickard Braanemark, MD, PhD, presently Research Scientist at the Biomechatronics Group at MIT Media Lab, Cambridge, MA, Associate Professor at the Department of Orthopaedics, Gothenburg University, Gothenburg, Sweden, Professor Emeritus at the Department of Orthopaedics, University of California, San Francisco, CA, Chairman and Founder of Integrum AB, a public company listed on First North, NASDAQ, Stockholm, Sweden, and one of the most experienced osseointegration orthopaedic surgeon in the world. He was the lead surgeon for the team that in 2013 treated a patient with an above elbow amputation with a combination of a percutaneous osseointegrated implant and implanted muscle and nerve electrodes. He received the Hanger prize for his contribution to amputee treatment in 2007, the UCSF Presidential Chair Award in 2016, the Brian and Joyce Blatchford Prize in 2017, the Per Udd’en Prize in 2017, and the Henry Wallman Prize in 2019.. He has published more than 70 scientific peer-reviewed papers on different aspects of osseointegration ranging from material properties to in-depth patient interviews, with a special focus on clinical outcomes, biomechanics and interface analysis.
Staff member since 2022.
Shares in Integrum, own and party holders:
A-Shares: 640 000
B-Shares: 5 527 780
Dependent in relation to the Company and company management as well as dependent in relation to the Company larger shareholders.